pSivida Limited (PSD.AX) Receives $15 Million Payment from Alimera Sciences (ALIM)
4/29/2010 7:12:29 AM
More...
|
pSivida Corporation Names Paul Ashton, Ph.D. President and Chief Executive Officer
2/2/2009 7:24:51 AM
More...
|
pSivida Limited (PSD.AX) New Evaluation for Cardiovascular Drug Delivery
12/16/2008 6:34:45 AM
More...
|
pSivida Limited (PSD.AX) New Clinical Trial for Drug Delivery Device in AMD
12/11/2008 6:34:18 AM
More...
|
pSivida Limited (PSD.AX) Reports Results for the First Quarter Ended September 30, 2008
11/11/2008 1:52:03 PM
More...
|
pSivida Limited (PSD.AX) Release: Results From The Six-Month Interim Readout Of The Human PK Iluvien(TM) Study
10/1/2008 11:05:39 AM
More...
|
pSivida Limited (PSD.AX) Announcement: DSMB Supports Continuation of the Phase III Clinical Trial of Iluvien(TM) for the Treatment of DME
9/25/2008 8:47:41 AM
More...
|
pSivida Limited (PSD.AX) Quarterly Highlights
7/31/2008 11:17:29 AM
More...
|
pSivida Limited (PSD.AX) Announces New Board Appointments
7/14/2008 8:42:16 AM
More...
|
pSivida Limited (PSD.AX): BrachySil™ Phase IIb Pancreatic Cancer Trials Commence
7/7/2008 10:34:09 AM
More...
|
|